FDA Drug Safety Oversight Board

The companies will collaborate to create and test circVec DNA–LNP formulations for use in potential therapeutic applications.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

CHMP has granted Eisai Europe and Biogen a positive opinion for the use of their monoclonal antibody therapy in treating early Alzheimer’s disease.

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Executives at Avantor talk about the future of the biopharmaceutical industry and the anticipated impact that a wave of next-generation biotherapeutics will bring.

The new Institute for Cell Therapy Discovery and Innovation will utilize expertise to develop cell therapies for cancer, autoimmune diseases, and infections.